• 1
    Swanson G, Ward J. Recruiting minorities into clinical trials: toward a participant- friendly system. J Natl Cancer Inst 1995; 87: 174759.
  • 2
    Murdaugh C. Recruitment issues in research with special populations. J Cardiovasc Nurs 1990; 4: 515.
  • 3
    Giuliano A, Mokuau N, Hughes C, Tortolero-Luna G, Risendal B, Ho R, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 2000; 10: S2234.
  • 4
    Vollmer W, Svetkey L, Appel L, Obarzanek E, Reams P, Kennedy B, et al. Recruitment and retention of minority participants in the DASH controlled feeding trial. Ethn Dis 1998; 8: 198208.
  • 5
    Helmuth L. NIH, under pressure, boosts minority health research. Science 2000; 288: 5967.
  • 6
    Skoularigis J, Eitzman L, Davis J, Strugo V. Sareli P. Nifedipine versus captopril in the management of moderate hypertension in black patients. Am J Hypertens 1994; 7: 4407.
  • 7
    Evans WE, McLeod HL. Drug therapy: pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 53849.
  • 8
    Charles H, Good CB, Hanusa BH, Chang CC, Whittle J. Racial differences in adherence to cardiac medications. J Natl Med Assoc 2003; 95: 1723.
  • 9
    Mosley-Williams A, Lumley MA, Gillis M, Leissen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002; 47: 6308.
  • 10
    Schumacher HR, Gall EP. Rheumatoid arthritis: an illustrated guide to pathology, diagnosis, and management. Philadelphia: JB Lippincott; 1988.
  • 11
    Lawrence RC. Classification and epidemiology. In: Klippel JH, Dieppe PA, editors. Rheumatology. St. Louis: Mosby; 1994. p. 14.
  • 12
    Felson DT. Epidemiology of the rheumatic diseases. In: McCarty DJ, Koopman MJ, editors. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lea & Febiger; 1993. p. 1747.
  • 13
    Soren A. Arthritis and related affections: clinic, pathology, and treatment. New York: Springer-Verlag; 1993.
  • 14
    Ness R, Nelson D, Kumanyika S, Grisso J. Evaluating minority recruitment into clinical studies: how good are the data? Ann Epidemiol 1997; 7: 4728.
  • 15
    Fouad M, Partridge E, Green B, Kohler C, Wynn T, Nagy S, et al. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and community. Ann Epidemiol 2000; 10: S3540.
  • 16
    Larson E. Exclusion of certain groups from clinical research. Image J Nurs Sch 1994; 26: 18590.
  • 17
    Freimuth V, Crouse Quinn S, Thomas S, Cole G, Zook E, Duncan T. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med 2001; 52: 797808.
  • 18
    McCarthy C. Historical background of clinical trials involving women and minorities. Acad Med 1994; 69: 6958.
  • 19
    DeVellis BM, Blalock SJ, Hahn PM, CeVellis RF, Hochbaum GM. Evaluation of a problem-solving intervention for patients with arthritis. Pt Educ Couns 1988; 11: 2942.
  • 20
    Lorish CD, Richards B, Brown S. Perspective of the patient with rheumatoid arthritis on issues related to missed medication. Arthritis Care Res 1990; 3: 7897.
  • 21
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 22
    Kahn R, Goldfarb A, Pollack M, Peck A. Brief objective measures for the determination of mental status in the aged. Am J Psychol 1960; 117: 3268.
  • 23
    Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette VL. How often is medication taken as prescribed: a novel assessment technique. JAMA 1989; 261: 32737.
  • 24
    City of Pittsburgh. 1990 census of population and housing reports. Pittsburgh: Department of City Planning; 1991. p. 22.
  • 25
    Holcombe R, Jacobson J, Li A, Moinpour C. Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience. Am J Clin Oncol 1998; 22: 1821.
  • 26
    Lewis C, George V, Fouad M, Porter V, Bowen D, Urban N. Recruitment strategies in the women's health trial: feasibility study in minority populations. Control Clin Trials 1998; 19: 46176.
  • 27
    Stallings F, Ford M, Simpson N, Fouad M, Jernigan J, Trauth J, et al. Black participation in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial. Control Clin Trials 2000; 21: 379S389S.
  • 28
    Padgett DK, Patrick C, Burns BJ, Schlesinger HJ. Ethnicity and the use of patient mental health services in a national insured population. Am J Public Health 1994; 84: 2226.
  • 29
    Nelson D, Kleerekoper M, Pawluszka A, Kirk C, Siegel D, Jacobsen G, et al. Recruitment of older African American and white women for a longitudinal study of skeletal health. J Womens Health 1993; 2: 35966.
  • 30
    Meilahn EN, Matthews KA, Egeland G, Kelsey SF. Characteristics of women with hysterectomy. Maturitas 1989; 11: 31929.
  • 31
    Winick C. Epidemiology of alcohol and drug abuse. In: Lawinson JH, Ruiz P, Millman RB, editors. Substance abuse: a comprehensive textbook. Baltimore: Williams & Wilkins; 1992. p. 1529.
  • 32
    Flewelling RL, Rachal JV, Marsden ME. Socioeconomic and demographic correlates of drug and alcohol use: findings from the 1988 and 1990 National Household Surveys on Drug Abuse. Rockville (MD): USDHHS Publication #92-1906; 1992. p. 2181.
  • 33
    Collins JF, Bingham SF, Williford WO, Weiss DG. Who drops out of clinical trials: the VA Cooperative Study experience. Control Clin Trials 1981; 2: 78.
  • 34
    Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) study. Control Clin Trials 1987; 8: 68S73S.